Effect of trifluridine/tipiracil in combination with bevacizumab on ECOG-PS in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial

被引：0

作者：

Taieb, Julien

Prager, Gerald W.

Fakih, Marwan

Ciardello, Fortunato

Van Cutsem, Eric

Elez, Elena

Cruz, Felipe Melo

Wyrwicz, Lucjan

Stroyakovskiy, Daniil

Papai, Zsuzsanna

Poureau, Pierre-Guillaume

Liposits, Gabor

Cremolini, Chiara

Bondarenko, Igor

Modest, Dominik Paul

Amellal, Nadia

Hassan, Hasnaa

Skanji, Donia

Tabernero, Josep

机构：

[1] Paris Cite Univ, Paris, France

[2] Med Univ Vienna, Vienna, Austria

[3] City Hope Natl Comprehens Canc Ctr, Duarte, CA USA

[4] Univ Campania Luigi Vanvitelli, Naples, Italy

[5] Univ Hosp Gasthuisberg Leuven, Dept Gastroenterol Digest Oncol, Leuven, Belgium

[6] Katholieke Univ Leuven, Leuven, Belgium

[7] Vall Hebron Univ Hosp, Barcelona, Spain

[8] Nucl Pesquisa Ensino Rede Sao Camilo, Sao Paulo, Brazil

[9] Maria Sklodowska Curie Natl Canc Res Inst, Dept Radiotherapy & Oncol, Warsaw, Poland

[10] Moscow City Oncol Hosp 62, Moscow, Russia

[11] Hungarian Def Forces Med Ctr, Dept Oncol, Budapest, Hungary

[12] Univ Hosp, Dept Oncol, Brest, France

[13] Reg Hosp West Jutland, Herning, Denmark

[14] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy

[15] Univ Pisana, Unit Med Oncol 2, Azienda Osped, Pisa, Italy

[16] Dnipro State Med Univ, Dnipro, Ukraine

[17] Charite Univ Med Berlin, Dept Med Hematol Oncol & Canc Immunol, Berlin, Germany

[18] Servier Int Res Inst, Suresnes, France

[19] Vall Hebron Univ Hosp, Barcelona, Spain

[20] Vall Hebron Inst Oncol VHIO, Barcelona, Spain

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3594

引用

页数：1

共 50 条

[1] Health-related quality of life associated with trifluridine/tipiracil in combination with bevacizumab in refractory metastatic colorectal cancer: An analysis of the phase 3 SUNLIGHT trial
Prager, G.
Taieb, J.
Fakih, M.
Ciardiello, F.
Van Cutsem, E.
Elez, E.
Cruz, F.
Wyrwicz, L.
Stroyakovskiy, D.
Papai, Z.
Poureau, P.
Liposits, G.
Cremolini, C.
Bondarenko, I.
Modest, D.
Amellal, N.
Hassan, H.
Skanji, D.
Tabernero, J.
ANNALS OF ONCOLOGY, 2023, 34 : S184 - S184
[2] Efficacy and safety of trifluridine/tipiracil in combination with bevacizumab in older and younger patients with refractory metastatic colorectal cancer: A subgroup analysis of the phase 3 SUNLIGHT trial.
Taieb, Julien
Prager, Gerald W.
Fakih, Marwan
Ciardello, Fortunato
Van Cutsem, Eric
Elez, Elena
Cruz, Felipe Melo
Wyrwicz, Lucjan S.
Stroyakovskiy, Daniil
Papai, Zsuzsanna
Poureau, Pierre-Guillaume
Liposits, Gabor
Cremolini, Chiara
Bondarenko, Igor
Modest, Dominik Paul
Roby, Lucas
Barboux, Valentine
Amellal, Nadia
Tabernero, Josep
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 111 - 111
[3] Plain language summary of SUNLIGHT: trifluridine/tipiracil and bevacizumab for refractory metastatic colorectal cancer
Prager, Gerald W.
Taieb, Julien
Fakih, Marwan
Ciardiello, Fortunato
Cutsem, Eric Van
Elez, Elena
Wyrwicz, Lucjan
Stroyakovskiy, Daniil
Liposits, Gabor
Bondarenko, Igor
Modest, Dominik P.
Amellal, Nadia
Tabernero, Josep
FUTURE ONCOLOGY, 2024,
[4] Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer
Prager, Gerald W.
Taieb, Julien
Fakih, Marwan
Ciardiello, Fortunato
Van Cutsem, Eric
Elez, Elena
Cruz, Felipe M.
Wyrwicz, Lucjan
Stroyakovskiy, Daniil
Papai, Zsuzsanna
Poureau, Pierre-Guillaume
Liposits, Gabor
Cremolini, Chiara
Bondarenko, Igor
Modest, Dominik P.
Benhadji, Karim A.
Amellal, Nadia
Leger, Catherine
Vidot, Loick
Tabernero, Josep
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (18): : 1657 - 1667
[5] Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: the phase 3 randomized SUNLIGHT study
Modest, D. P.
Tabernero, J.
Prager, G.
Fakih, M.
Ciardiello, F.
Van Cutsem, E.
Elez, E.
Cruz, F.
Wyrwicz, L.
Stroyakovskiy, D.
Papai, Z.
Poureau, P. -G.
Liposits, G.
Cremolini, C.
Benhadji, K.
Bondarenko, I.
Skanji, D.
Roby, L.
Amellal, N.
Taieb, J.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 157 - 158
[6] Trifluridine/tipiracil plus bevacizumab for third-line treatment of refractory metastatic colorectal cancer: The phase 3 randomized SUNLIGHT study.
Tabernero, Josep
Prager, Gerald W.
Fakih, Marwan
Ciardiello, Fortunato
Van Cutsem, Eric
Elez, Elena
Cruz, Felipe Melo
Wyrwicz, Lucjan
Stroyakovskiy, Daniil
Papai, Zsuzsanna
Poureau, Pierre-Guillaume
Liposits, Gabor
Cremolini, Chiara
Bondarenko, Igor
Modest, Dominik Paul
Benhadji, Karim A.
Fougeray, Ronan
Leger, Catherine
Amellal, Nadia
Taieb, Julien
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 4 - 4
[7] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: A retrospective study
Li, Rongrong
Zhou, Hui-Jun
Zeng, De-Yu
Jiang, Shao-Feng
Liu, Wu
Liu, Zhen-yang
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[8] Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial
Tabernero, J.
Taieb, J.
Fakih, M.
Prager, G. W.
Van Cutsem, E.
Ciardiello, F.
Mayer, R. J.
Amellal, N.
Skanji, D.
Calleja, E.
Yoshino, T.
ESMO OPEN, 2024, 9 (03)
[9] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
Li, Rong-Rong
Zhou, Hui-Jun
Zeng, De-Yu
Jiang, Shao-Feng
Liu, Wu
Fruehling, Petter
Liu, Zhen-Yang
JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 612 - 629
[10] QTWiST analysis of the RECOURSE trial of trifluridine/tipiracil in metastatic colorectal cancer
Tabernero, Josep
Van Cutsem, Eric
Ohtsu, Atsushi
Amellal, Nadia
Cadour, Stephanie
Fougeray, Ronan
Haffemayer, Benjamin
Mayer, Robert J.
ESMO OPEN, 2017, 2 (05)

← 1 2 3 4 5 →